ta-65
Small moleculeexperimental
Clinical trial activity
6 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2013 (NCT01753674)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Telomerase reverse transcriptaseACTIVATOR
TERT activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ta-65
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05598359 | N/A | Jan 1, 2023 | Medical College of Wisconsin, Pennsylvania State University, University of Louisville |
| NCT05500742 | N/A | Aug 31, 2022 | University of Bologna |
| NCT02731807 | Phase 1 | Sep 1, 2016 | New York University |
| NCT02766790 | N/A | May 1, 2016 | QPS, Telomerase Activation Sciences, Inc |
| NCT02531334 | N/A | Aug 1, 2015 | University of Connecticut |
| NCT01753674 | Phase 1 | Jan 1, 2013 | University of Connecticut |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Connecticut | Academic/Hospital | 2 | 2 | 2 | 2013 |
| Medical College of Wisconsin | Academic/Hospital | 1 | 1 | 1 | 2023 |
| New York University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Pennsylvania State University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| QPS | For profit | 1 | 0 | 1 | 2016 |
| Telomerase Activation Sciences, Inc | For profit | 1 | 1 | 1 | 2016 |
| University of Bologna | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Louisville | Academic/Hospital | 1 | 0 | 1 | 2023 |
8 organizations
Page 1 / 1